Suven Pharma shares zooms 12% on strong Q3 nos; PAT up 78%, rev 39%

Quick Summary:

Suven Pharma reported a 78 per cent rise in consolidated net profit during the third quarter to Rs 83.29 crore, as compared to Rs 46.

Suven Pharmaceuticals also offers contract research and manufacturing services (CRAMS) to global pharmaceutical companies.

Ebitda margin for the quarter under view stood at 23.1 per cent against 35.4 per cent a year ago.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Buzzing stocks Nifty50 Suven pharma q3 results Suven pharma share Market today Bse Suven pharma stock price Nse Suven pharma share price Suven pharma stock news Markets Suven pharma results Nse

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-02-13 @ 13:14:42 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 401 words

Reading Time: 3 minutes read

Sentences: 19 lines

Sentence Length: 22 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 26114386

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 272 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions